Current pharmacological treatments for SARS-COV-2: A narrative review

The novel coronavirus, later identified as SARS-CoV-2, originating from Wuhan in China in November 2019, quickly spread around the world becoming a pandemic. Despite the knowledge of previous coronaviruses, such as those responsible for the SARS and MERS-CoV epidemic, there is no drug or prophylaxis...

Descripción completa

Detalles Bibliográficos
Autores principales: Nittari, Giulio, Pallotta, Graziano, Amenta, Francesco, Tayebati, Seyed Khosrow
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320862/
https://www.ncbi.nlm.nih.gov/pubmed/32603692
http://dx.doi.org/10.1016/j.ejphar.2020.173328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320862/
https://www.ncbi.nlm.nih.gov/pubmed/32603692
http://dx.doi.org/10.1016/j.ejphar.2020.173328

Ejemplares similares